504 related articles for article (PubMed ID: 6297337)
1. Evaluation in swine of a subunit vaccine against pseudorabies.
Maes RK; Schutz JC
Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337
[TBL] [Abstract][Full Text] [Related]
2. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
Arellano PE; Morrison RB; Molitor TW; Thawley DG
J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
[TBL] [Abstract][Full Text] [Related]
3. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure.
Kelling CL; Staudinger WL; Rhodes MB
Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.
van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659
[TBL] [Abstract][Full Text] [Related]
5. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus.
van Oirschot JT; Gielkens AL
Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645
[TBL] [Abstract][Full Text] [Related]
6. Effect of various vaccination procedures on shedding, latency, and reactivation of attenuated and virulent pseudorabies virus in swine.
Mengeling WL; Lager KM; Volz DM; Brockmeier SL
Am J Vet Res; 1992 Nov; 53(11):2164-73. PubMed ID: 1466515
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus.
McGregor S; Easterday BC; Kaplan AS; Ben-Porat T
Am J Vet Res; 1985 Jul; 46(7):1494-7. PubMed ID: 2992326
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
Mikulska-Skupień E; Szweda W; Procajło Z
Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
[TBL] [Abstract][Full Text] [Related]
9. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a pseudorabies virus vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I.
van Oirschot JT; Moormann RJ; Berns AJ; Gielkens AL
Am J Vet Res; 1991 Jul; 52(7):1056-60. PubMed ID: 1654033
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus.
van Oirschot JT; Daus F; Kimman TG; van Zaane D
Am J Vet Res; 1991 Nov; 52(11):1788-93. PubMed ID: 1664670
[TBL] [Abstract][Full Text] [Related]
12. Antibody response of pigs to inactivated monovalent and bivalent vaccines for porcine parvovirus and pseudorabies virus.
Mengeling WL; Gutekunst DE; Pirtle EC
Am J Vet Res; 1980 Oct; 41(10):1569-71. PubMed ID: 6261613
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a killed gpX deleted pseudorabies virus vaccine.
Cook DR; Hill HT; Kinker DR
Can J Vet Res; 1990 Oct; 54(4):438-45. PubMed ID: 2174294
[TBL] [Abstract][Full Text] [Related]
14. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
Kit S; Kit M; McConnell S; Lawhorn B
Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
[TBL] [Abstract][Full Text] [Related]
15. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
Van Oirschot JT
Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
[TBL] [Abstract][Full Text] [Related]
16. Vaccination against pseudorabies with glycoprotein gI+ or glycoprotein gI- vaccine.
Vandeputte J; Chappuis G; Fargeaud D; Précausta P; Guillemin F; Brun A; Desmettre P; Stellmann C
Am J Vet Res; 1990 Jul; 51(7):1100-6. PubMed ID: 2167620
[TBL] [Abstract][Full Text] [Related]
17. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
18. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
De Leeuw PW; Van Oirschot JT
Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
[TBL] [Abstract][Full Text] [Related]
19. Genetic differences in serum-neutralization titers of pigs after vaccination with pseudorabies modified live-virus vaccine.
Rothschild MF; Hill HT; Christian LL; Warner CM
Am J Vet Res; 1984 Jun; 45(6):1216-8. PubMed ID: 6331234
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
